Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Hub Group, Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Legal Action and Investor Rights - Investors who purchased Hub Group securities may be entitled to compensation through a contingency fee arrangement, with a class action being prepared to recover investor losses [2]. - Interested investors can join the prospective class action by submitting a form or contacting the law firm directly [2]. Group 2: Financial Reporting Issues - On February 5, 2026, Hub Group filed a Current Report with the SEC, revealing an error that led to the understatement of purchased transportation costs and accounts payable for the first nine months of 2025 [3]. - As a result of this error, Hub Group plans to restate its financial statements for the first three quarters of 2025 [3]. - Following the announcement, Hub Group's stock price dropped by $9.37 per share, or 18.3%, closing at $41.96 per share on February 6, 2026 [3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. - The firm has achieved significant settlements for investors, including the largest securities class action settlement against a Chinese company and has been consistently ranked among the top firms for securities class action settlements [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering substantial amounts for its clients [4].

Hagens Berman Investigating Claims Against Ardent Health (ARDT) Over Alleged $97M Accounting Shock and "180-Day Cliff" Reserves [Accessibility Statement] Skip NavigationARDT Investors with Losses Encouraged to Contact the FirmSAN FRANCISCO, Feb. 20, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is notifying investors in Ardent Health, Inc. (NYSE: ARDT) regarding the March 9, 2026, lead plaintiff deadline in a pending securities class action the company and certain of its top execut ...

Core Viewpoint - Hagens Berman is notifying investors of Klarna Group plc regarding a lead plaintiff deadline in a securities class action related to alleged misstatements in the company's September 2025 IPO documents [1] Group 1: Allegations and Investigations - The lawsuit claims that Klarna's IPO documents misled investors by highlighting its credit modeling performance while failing to disclose aggressive lending practices to financially unsophisticated consumers [1] - Following the IPO, Klarna reported a 102% year-over-year increase in its provision for credit losses, leading to a significant drop in its stock price, trading nearly 22% below the IPO price [1] - The complaint alleges that Klarna's growth was driven by high-frequency, high-interest loans for non-durable goods, which critics argue target financially vulnerable consumers and increase default risk [1] Group 2: Financial Impact - Klarna's stock price fell sharply after the announcement of the increased credit loss provisions, raising concerns about the transparency of its IPO documents [1] - The lawsuit highlights that the offering documents materially understated the credit risks associated with lending to financially unsophisticated clients [1] Group 3: Next Steps for Investors - Investors who purchased Klarna shares during the September 2025 IPO and experienced losses are encouraged to contact Hagens Berman before the February 20, 2026, deadline [1] - Hagens Berman is recognized for prosecuting securities fraud class actions and is actively advising affected investors [1]

Core Viewpoint - Faruqi & Faruqi, LLP is reminding investors of F5, Inc. about the deadline for a securities class action lawsuit, which is set for February 17, 2026, due to allegations of misleading statements related to a significant security breach affecting the company's capabilities [1] Group 1: Company Overview - F5, Inc. (NASDAQ: FFIV) is facing a federal securities class action lawsuit alleging violations of federal securities laws by making false or misleading statements regarding its security capabilities [1] - The lawsuit claims that F5 was experiencing a significant security breach that impacted its ability to secure client data, which was not disclosed to investors [1] Group 2: Financial Impact - On October 27, 2025, F5 reported fourth quarter fiscal year 2025 results that fell significantly below market growth expectations for fiscal 2026, largely attributed to the security breach [1] - Following the announcement, F5's stock price dropped from $290.41 per share on October 27, 2025, to $258.76 per share by October 29, 2025, marking a decline of 10.9% in just two days [1] Group 3: Legal Proceedings - The deadline for investors to seek the role of lead plaintiff in the class action lawsuit is February 17, 2026, and any member of the class can move the court to serve as lead plaintiff [1] - Faruqi & Faruqi encourages individuals with information regarding F5's conduct, including whistleblowers and former employees, to come forward [1]

Core Viewpoint - ICON plc's shares plummeted approximately 49% following the announcement of an investigation into its revenue recognition practices for fiscal years 2023 to 2025, resulting in a loss of over $5 billion in market capitalization in a single day [1]. Group 1: Investigation Details - The investigation is focused on the accuracy of ICON's past claims regarding the effectiveness of its internal controls over financial reporting and compliance with accounting rules [1]. - The investigation was initiated in late October 2025 and has revealed potential overstatements in revenue for the years 2023 and 2024 [1]. - ICON has indicated that it expects to report one or more material weaknesses in its internal control over financial reporting [1]. Group 2: Market Reaction - Following the disclosures, ICON withdrew its previously issued financial guidance for FY 2025, which was provided to investors on October 22, 2025 [1]. - The market's reaction was severe, with a 49% drop in share price, reflecting significant investor concern over the company's financial integrity [1]. Group 3: Legal Implications - Hagens Berman, a national shareholder rights law firm, is investigating whether ICON misled investors regarding its revenue recognition practices [1]. - The firm is encouraging investors who have suffered losses to come forward and discuss their rights [1].

Core Insights - Software and logistics stocks are experiencing significant sell-offs due to fears surrounding artificial intelligence, with logistics companies like C.H. Robinson and Universal Logistics facing double-digit losses [1] - Algorhythm Holdings has introduced a new AI-driven freight management tool that reportedly improves workforce productivity by 4x, leading to a surge in its stock price by as much as 79% before closing up 29% [2] - The market is currently reacting aggressively to any AI-related news, causing volatility across various sectors, including logistics and technology [3] Logistics Sector Impact - The announcement from Algorhythm Holdings negatively affected shares of major logistics companies such as Maersk and UPS, which saw smaller declines, while Hub Group's shares fell by around 6% [4] - The drop in logistics stocks coincided with declines in financial services and real estate sectors, triggered by the launch of AI-driven products from lesser-known companies [4] Broader Market Dynamics - The capital markets are facing multiple challenges, including equity market rotation, volatile commodity prices, geopolitical tensions, and central bank decisions, contributing to the overall market turmoil [4] - Despite positive earnings reports, companies like AppLovin still saw stock declines, indicating a broader skepticism towards AI as a catalyst for growth [5]

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against uniQure N.V. (NASDAQ: QURE) and reminds investors of the April 13, 2026 deadline to seek the role of lead plaintiff in a federal securities class action filed against the company [1] Summary by Relevant Sections Company Overview - uniQure N.V. is facing allegations of violating federal securities laws by making false or misleading statements regarding its Pivotal Study and the approval status of its BLA submission for AMT-130 [1] Legal Proceedings - The complaint alleges that the design of uniQure's Pivotal Study was not fully approved by the FDA, and that the company downplayed the likelihood of needing to delay its BLA timeline for additional studies [1] - On November 3, 2025, uniQure disclosed that the FDA no longer agreed that data from the Phase I/II AMT-130 studies would support a BLA submission, leading to a significant drop in share price [1] Financial Impact - Following the disclosure, uniQure's share price fell by $33.40, or over 49%, from $67.69 on October 31, 2025, to $34.29 on November 3, 2025 [1]

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Ramaco Resources, Inc. (NASDAQ: METC) related to a federal securities class action, with a deadline for investors to seek lead plaintiff status by March 31, 2026 [1]. Group 1: Allegations Against Ramaco Resources - The complaint alleges that Ramaco and its executives violated federal securities laws by making false and misleading statements and failing to disclose significant information regarding the Brook Mine [1]. - Specific allegations include that no significant mining activity had commenced at the Brook Mine after its groundbreaking, and that the company overstated development progress at the site [1]. - A report by Wolfpack Research described the Brook Mine as a "hoax" and indicated that no active work had occurred, supported by drone footage taken three months post-groundbreaking [1]. Group 2: Stock Price Impact - Following the publication of the Wolfpack Research report, Ramaco's stock price fell by $3.81, or 9.6%, closing at $36.01 per share on October 23, 2025, with unusually high trading volume [1]. Group 3: Legal Proceedings and Investor Actions - The court-appointed lead plaintiff will be the investor with the largest financial interest in the relief sought, who is also typical of class members [1]. - Any member of the putative class can move to serve as lead plaintiff or choose to remain an absent class member without affecting their ability to share in any recovery [1].

Core Viewpoint - A class action lawsuit has been filed against Inovio Pharmaceuticals, Inc. for alleged securities fraud, with investors who purchased shares between October 10, 2023, and December 26, 2025, potentially entitled to compensation [1]. Group 1: Lawsuit Details - The lawsuit claims that Inovio made false and misleading statements regarding its CELLECTRA device manufacturing and the likelihood of submitting the INO-3107 Biologics License Application (BLA) to the FDA by the second half of 2024 [1]. - It is alleged that Inovio lacked sufficient information to justify the INO-3107 BLA's eligibility for FDA accelerated approval or priority review, leading to overstated regulatory and commercial prospects [1]. - The lawsuit asserts that when the true details were revealed, investors suffered damages due to the misleading public statements made by the defendants [1]. Group 2: Legal Representation - The Rosen Law Firm, which is leading the class action, emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [1]. - The firm has a history of significant recoveries for investors, including over $438 million in 2019 alone, and has been recognized for its achievements in securities class action settlements [1]. - Investors interested in joining the class action can do so without upfront fees through a contingency fee arrangement [1].

on LinkedIn][Scott+Scott on X]Get RSS Feed## Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation Into Hub Group, Inc. (NASDAQ: HUBG)NEW YORK--([BUSINESS WIRE])--Scott+Scott Attorneys at Law LLP ("Scott+Scott†), a shareholder and consumer rights litigation firm, is investigating whether Hub Group, Inc. ("Hub Group†or the "Company†) (NASDAQ: HUBG) or certain of its officers and directors issued misleading and false statements and/or failed to disclose information material to investors i ...